Haemonetics Corporation (HAE) Q4 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Haemonetics Corporation.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.256 Hello, and welcome to the Q4 2026 00:00:03.256 -- 00:00:06.601 Hemonetics Corporations Earnings Conference Call. 00:00:06.601 -- 00:00:10.366 At this time, all participants are in a listen-only mode. 00:00:10.366 -- 00:00:13.391 After the speaker's presentation, there will be a question and answer session. 00:00:13.391 -- 00:00:19.620 To ask a question during the session, you will need to press star 1 1 on your telephone. 00:00:19.620 -- 00:00:23.446 You will then hear an automated message advising your hand is raised. 00:00:23.446 -- 00:00:27.291 To withdraw your question, please press star 1 1 again. 00:00:27.291 -- 00:00:31.047 Please be advised that today's conference is being recorded. 00:00:31.047 -- 00:00:35.211 I would now like to hand the conference over to Olga Goyet, Vice President of Investor 00:00:35.211 -- 00:00:39.314 Relations and Treasury. Please go ahead. 00:00:40.377 -- 00:00:44.361 Good morning, and thank you for joining us for Humanetics' fourth quarter fiscal year 00:00:44.361 -- 00:00:50.067 2026 conference call and webcast. I'm joined today by Chris Simon, our CEO, 00:00:50.067 -- 00:00:52.810 and James Dureka, our CFO. 00:00:52.810 -- 00:00:57.655 This morning, we released our fourth quarter and full fiscal 2026 results and issued 00:00:57.655 -- 00:01:02.939 fiscal year 2027 guidance. The materials, including our earnings release and supplemental 00:01:02.939 -- 00:01:07.765 earnings presentation, are available on our Investor Relations website and also in this 00:01:07.765 -- 00:01:10.268 morning's press release. 00:01:10.268 -- 00:01:14.954 Before we begin, I'd like to remind everyone that we will use both reported and organic 00:01:14.954 -- 00:01:19.239 revenue growth rates that exclude the impact of e...